Rawlins Quoted on Microsoft Corp. v. i4i
June 15, 2011
BNA’s Medical Devices Law & Industry Report
Foley Partner Andrew Rawlins was quoted in an article that appeared in BNA’s Medical Devices Law & Industry Report on June 15, 2011 titled “High Court Affirms Clear and Convincing Evidence Norm for Patent Validity Challenges.” Rawlins discusses the U.S. Supreme Court’s decision in Microsoft Corp. v. i4i Limited Partnership, which reaffirmed the patent invalidity standard established by the U.S. Court of Appeals for the Federal Circuit in 1984. He states that the decision could be viewed as a win for patent holders and a loss for possible infringers, adding that many companies will likely be glad that they can continue to rely on the deference given to the presumed validity of their patents.
People
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."
June 4, 2025
In the News
Foley Attorneys Explore IP Considerations for AI-Generated Logos
Foley & Lardner LLP attorneys Von Bryant, Norm Rich, and Alex Liederman authored the Bloomberg Law article, "AI-Generated Logos Require Careful Steps to Protect IP Rights."